References
- Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Rev Rheumatol. 2007;3(3):148–155.
- Cho M-L, Kim J-Y, Ko H-J, et al. The MCP-1 promoter -2518 polymorphism in Behcet’s disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity. 2004;37(1):77–80.
- Yurdakul S, Hamuryudan V, Yazici H. Behçet syndrome. Curr Opin Rheumatol. 2004;16(1):38–42.
- Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;77(6):808–818.
- Greco A, De Virgilio A, Ralli M, et al. Behçet’s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567–575.
- Kurokawa MS, Yoshikawa H, Suzuki N. Behcet’s disease. Semin Respir Crit Care Med. 2004;25:557–68.
- Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61(5):600–604.
- Takizawa K, Takeuchi F, Nabeta H, et al. Association of transporter associated with antigen processing genes with Behcet’s disease in Japanese. Autoimmunity. 2003;36(3):161–165.
- Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol. 2004;18(3):291–311.
- Basak C, Yunus S, Ahmet G, et al. Activation markers in Behçet’s disease. SKINmed. 2005;4(5):282–286.
- Türsen Ü. Activation markers in Behcet disease. TURKDERM-Arch Turk Dermatol Venerol. 2009;43:74–86.
- Ozturk C, Balta S, Balta I, et al. Neutrophil–lymphocyte ratio and carotid–intima media thickness in patients with Behcet disease without cardiovascular involvement. Angiology. 2015;66(3):291–296.
- Tanacan E, Dincer D, Erdogan F, et al. A cutoff value for the Systemic Immune‐Inflammation Index in determining activity of Behçet disease. Clin Exp Dermatol. 2021;46(2):286–291.
- Bardak Y, Aridogan BC. The demonstration of serum interleukin 6–8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet’s disease with ocular involvement. Ocular Immunol Inflam. 2004;12(1):53–58.
- Sharief M, Hentges R, Thomas E. Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet’s disease. Neurology. 1991;41(9):1398.
- Onat AM, Buyukhatipoglu H, Yilmaz M, et al. Immunoglobulin E: a new diagnostic clue for Behçet’s disease? IgE and Behçet’s disease Clin Rheumatol. 2007;26(1):81–83.
- Scully C, Boyle P, Yap P. Immunoglobulins G, M, A, D and E in Behcet’s syndrome. Clin Chim Acta. 1982;120(2):237–242.
- Bireller S, Küçükali Cİ, Hanağasi H, et al. Impact of neuro-Behçet disease immunoglobulin G on neuronal apoptosis. Noro Psikiyatr Ars. 2017;54(1):67–71.
- Lucherini O, Vitale A, Orlando I, et al. Serum immunoglobulin D levels in patients with Behçet’s disease according to different clinical manifestations. Clin Exp Rheumatol. 2018;36:110–115.
- Fleming SD. Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity. 2006;39(5):379–386.
- Gong W-y, Liu M, Luo D, et al. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study. BMC Nephrol. 2019;20(1):150.
- Kawasaki Y, Maeda R, Ohara S, et al. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy. Pediatr Int. 2018;60(2):162–167.
- Mohammed S, Ahmed RAEH, Sadek AA. Serum immunoglobulin G, IgM And IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. Sohag Med J. 2019;23(3):77–82.
- Lee BT, Wang Y, Yang A, et al. IgG:IgM ratios of liver plasma cells reveal similar phenotypes of primary biliary cholangitis with and without features of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2021;19(2):397–399.
- Domingues V, Magder LS, Petri M. Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE. Lupus Sci Med. 2016;3(1):e000107.
- Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458–472.
- Tong B, Liu X, Xiao J, et al. Immunopathogenesis of Behcet’s disease. Front Immunol. 2019;10:665.
- Aslani S, Mahmoudi M, Karami J, et al. Epigenetic alterations underlying autoimmune diseases. Autoimmunity. 2016;49(2):69–83.